Better Coordination, Planning Needed for Overseas Offices

Better coordination between the FDA’s overseas offices and their domestic counterparts, as well as long-term strategic planning, is needed to improve the role of those offices in the face of growing regulatory challenges, the Government Accountability Office reports. Although the overseas offices have been collecting information on regulated products manufactured in foreign countries to ensure the safety of imported devices, feedback from the FDA to those offices is lacking, according to the report released last month.
The GMP Letter